跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,286 条关于
“SER-270”
全部
10,286
临床试验
7,748
药物
1,374
机构
95
资讯
1,069
去年
Serina Therapeutics Advances Once-Weekly Injectable VMAT2 Inhibitor for Tardive Dyskinesia Treatment
2个月前
Tardive Dyskinesia Market Projected to Reach USD 4.4 Billion by 2036, Growing at 8.1% CAGR Amid Pipeline Innovation
去年
Serina Therapeutics' SER-252 to Enter Clinical Trials for Advanced Parkinson's Disease
7个月前
Serina Therapeutics Receives FDA IND Clearance for SER-252 Parkinson's Disease Therapy
去年
Seres Therapeutics' SER-155 Shows Promise for Immune Recovery in Stem Cell Transplant Patients
9个月前
Serina Therapeutics Responds to FDA Clinical Hold on SER-252 Parkinson's Disease Treatment
去年
Seres Therapeutics Appoints Co-CEOs as Company Seeks Partnerships for SER-155 Development
去年
Seres Therapeutics' SER-155 Shows Promise in Reducing Bloodstream Infections Post-Stem Cell Transplant
去年
Serina Therapeutics Gains $10M to Advance Parkinson's Drug SER-252 into Phase 1
去年
Adicet Bio Initiates Phase 1 Trial of ADI-270, a Novel CAR T-cell Therapy for Advanced Kidney Cancer
第 1 页,共 107 页
上一页
下一页